Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03742921
Brief Title: ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

First Submitted : November 13, 2018
First Submitted that Met QC Criteria : November 13, 2018
First Posted : November 15, 2018

Last Update Submitted that Met QC Criteria : June 3, 2020
Last Update Posted : June 4, 2020